NCT05965024View on ClinicalTrials.gov

Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer

RecruitingOBSERVATIONAL

Enrollment

377

Participants

Timeline

Start Date

October 25, 2023

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2028

Conditions

Non-small Cell Lung Cancer

Trial Locations (1)

200433

RECRUITING

Shanghai Pulmonary Hospital, Shanghai

All Listed Sponsors

lead

Shanghai Pulmonary Hospital, Shanghai, China

OTHER